707 related articles for article (PubMed ID: 25715318)
1. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
2. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
3. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
5. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
7. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children.
Zhang Y; Wang L; Liao Y; Liu L; Ma K; Yang E; Wang J; Che Y; Jiang L; Pu J; Guo L; Feng M; Liang Y; Cui W; Yang H; Li Q
Vaccine; 2015 Nov; 33(46):6290-7. PubMed ID: 26419198
[TBL] [Abstract][Full Text] [Related]
8. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
Klein MH
Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
[TBL] [Abstract][Full Text] [Related]
9. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
10. Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.
Li J; Liu G; Liu X; Yang J; Chang J; Zhang W; Yu XF
Viruses; 2015 Jul; 7(7):3891-909. PubMed ID: 26193302
[TBL] [Abstract][Full Text] [Related]
11. Review of enterovirus 71 vaccines.
Chong P; Liu CC; Chow YH; Chou AH; Klein M
Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease.
Liu D; Leung K; Jit M; Yu H; Yang J; Liao Q; Liu F; Zheng Y; Wu JT
Clin Microbiol Infect; 2020 Mar; 26(3):373-380. PubMed ID: 31279839
[TBL] [Abstract][Full Text] [Related]
13. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
Fan S; Liao Y; Jiang G; Jiang L; Wang L; Xu X; Feng M; Yang E; Zhang Y; Cui W; Li Q
Vaccine; 2020 Feb; 38(8):2034-2044. PubMed ID: 31982260
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
[TBL] [Abstract][Full Text] [Related]
15. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.
Rabenau HF; Richter M; Doerr HW
Med Microbiol Immunol; 2010 Feb; 199(1):45-51. PubMed ID: 19941005
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
Fan S; Liao Y; Jiang G; Wang L; Zhao H; Yu L; Xu X; Li D; Zhang Y; Li Q
Vaccine; 2021 Jan; 39(3):596-604. PubMed ID: 33342637
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
18. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
Zhu F; Xu W; Xia J; Liang Z; Liu Y; Zhang X; Tan X; Wang L; Mao Q; Wu J; Hu Y; Ji T; Song L; Liang Q; Zhang B; Gao Q; Li J; Wang S; Hu Y; Gu S; Zhang J; Yao G; Gu J; Wang X; Zhou Y; Chen C; Zhang M; Cao M; Wang J; Wang H; Wang N
N Engl J Med; 2014 Feb; 370(9):818-28. PubMed ID: 24571754
[TBL] [Abstract][Full Text] [Related]
20. Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.
Zhu W; Jin P; Li JX; Zhu FC; Liu P
Expert Rev Vaccines; 2017 Sep; 16(9):945-949. PubMed ID: 28548626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
